| Prostate Cancer |
1 |
1 |
| Hereditary Nonpolyposis Colorectal Cancer (HNPCC) |
0 |
0.75 |
| Cancer |
0 |
0.73 |
| Colorectal Cancer |
0 |
0.69 |
| Prostate Specific Antigen |
0 |
0.61 |
| Biologic Therapy |
0 |
0.59 |
| Cancer Risk |
0 |
0.58 |
| Prostate |
0 |
0.53 |
| Genomic Medicine |
0 |
0.47 |
| Preventive Screening |
0 |
0.17 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.1 |
| Tumor |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.07 |
| Antigens |
0 |
0.03 |
| Biopsy |
0 |
0.03 |
| Europe |
0 |
0.03 |
| Genetics |
0 |
0.03 |
| Match |
0 |
0.03 |
| Medical Life |
0 |
0.03 |